A Case of Pancreatic Neuroendocrine Tumor G3 Which Responded Remarkably to Chemotherapy.


Journal

Journal of UOEH
ISSN: 0387-821X
Titre abrégé: J UOEH
Pays: Japan
ID NLM: 7909645

Informations de publication

Date de publication:
2022
Historique:
entrez: 11 9 2022
pubmed: 12 9 2022
medline: 14 9 2022
Statut: ppublish

Résumé

Pancreatic neuroendocrine carcinoma (NEC) as classified in the World Health Organization (WHO) 2010 was reclassified in the WHO 2017 as either neuroendocrine tumor (NET) G3 or NEC. An accurate diagnosis based on the WHO 2017 classification is important in order treating this disease appropriately. We report a case diagnosed as NET G3 that responded remarkably well to treatment with streptozocin. The patient would likely not have received the streptozocin treatment if she had been diagnosed with NEC. The WHO 2017 classification is reasonable for the treatment of advanced pancreatic neuroendocrine neoplasms.

Identifiants

pubmed: 36089347
doi: 10.7888/juoeh.44.287
doi:

Substances chimiques

Streptozocin 5W494URQ81

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

287-292

Auteurs

Satoru Nebuya (S)

Third Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.

Shinji Oe (S)

Third Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.

Yoshikazu Harada (Y)

Department of Pathology and Cell Biology, School of Medicine, University of Occupational and Environmental Health, Japan.

Yusuke Takeuchi (Y)

Third Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.

Akitoshi Yoneda (A)

Third Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.

Yudai Koya (Y)

Third Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.

Koichiro Miyagawa (K)

Third Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.

Yuichi Honma (Y)

Third Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.

Michihiko Shibata (M)

Third Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.

Masaru Harada (M)

Third Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH